ARQ vs. ASPI, FTK, ZTEK, FSI, ESI, CBT, WDFC, OEC, BBSI, and HCSG
Should you be buying ARQ stock or one of its competitors? The main competitors of ARQ include ASP Isotopes (ASPI), Flotek Industries (FTK), Zentek (ZTEK), Flexible Solutions International (FSI), Element Solutions (ESI), Cabot (CBT), WD-40 (WDFC), Orion (OEC), Barrett Business Services (BBSI), and Healthcare Services Group (HCSG).
ASP Isotopes (NASDAQ:ASPI) and ARQ (NASDAQ:ARQ) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.
In the previous week, ASP Isotopes had 1 more articles in the media than ARQ. MarketBeat recorded 3 mentions for ASP Isotopes and 2 mentions for ARQ. ASP Isotopes' average media sentiment score of 0.74 beat ARQ's score of 0.55 indicating that ARQ is being referred to more favorably in the news media.
ARQ has higher revenue and earnings than ASP Isotopes. ARQ is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.
16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 18.5% of ARQ shares are held by institutional investors. 26.3% of ASP Isotopes shares are held by company insiders. Comparatively, 22.2% of ARQ shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
ASP Isotopes has a net margin of 0.00% compared to ASP Isotopes' net margin of -8.15%. ASP Isotopes' return on equity of -4.65% beat ARQ's return on equity.
ASP Isotopes has a beta of 5.12, meaning that its stock price is 412% more volatile than the S&P 500. Comparatively, ARQ has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.
ASP Isotopes presently has a consensus price target of $5.50, suggesting a potential upside of 100.00%. Given ARQ's higher possible upside, analysts plainly believe ASP Isotopes is more favorable than ARQ.
ASP Isotopes received 3 more outperform votes than ARQ when rated by MarketBeat users. Likewise, 100.00% of users gave ASP Isotopes an outperform vote while only 0.00% of users gave ARQ an outperform vote.
Summary
ASP Isotopes beats ARQ on 10 of the 17 factors compared between the two stocks.
Get ARQ News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ARQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
